You are currently viewing Watch on demand: DSM and Brains Bioceutical present at CT-Cann 2023 Leading Industry Session

Watch on demand: DSM and Brains Bioceutical present at CT-Cann 2023 Leading Industry Session

Gain valuable insights into the early-stage drug development of cannabidiol (CBD) from industry experts Terry O’Regan, President of Brains Bioceutical, and Alexandru Zabara, Innovation Manager of Pharma at DSM.

Get an expert view on how to unlock cannabinoid therapeutic innovation by advancing the scientific landscape, as well as approaches to addressing the challenge of CBD bioavailability: modulating physical properties of selected formulations in order to enhance in-vitro bioaccessibility and in-vivo pharmacokinetic performance.